4 Jun 2026Open access
Correction: Methotrexate-lactoferrin targeted exemestane cubosomes for synergistic breast cancer therapyPublisher siteFrontiers in Chemistry, Lipid Membrane Structure and Behavior
Active, last published 2026
In synthesis and biological activity
Mohamed
Teleb
Scholar“Research focused on Synthesis and biological activity and adjacent fields.”
Claim Your Profile24
H-index
1.6k
Citations
Mohamed has not officially claimed their profile. If you are Mohamed, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ohamed Teleb is a researcher working on Synthesis and biological activity. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Mohamed's work has been cited 1,552 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Synthesis and biological activity×15Peptidase Inhibition and Analysis×14Nanoparticle-Based Drug Delivery×11Click Chemistry and Applications×11Synthesis and Biological Evaluation×9
04 · Where I am
Affiliations
Affiliation on published researchApplied Nanotech (United States), EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
15 works25 Nov 2025Open access
Corrigendum to “Ultrasmall lactoferrin/lipid multicompartmental nanomedicine-based reprogramming of glycolysis in triple-negative breast cancer via HDAC6/LDH axis enhances cancer immunotherapy” [Chem. Eng. J. (CEJ) volume 514, 15 June 2025, 163015]Publisher siteChemical Engineering Journal
1 Sept 2025Open access
Pharmacological Characterization of the Novel CRF1 Receptor Antagonist, Thiazolo[4,5-d] Pyrimidine Analog, M43Publisher siteBiomolecules, Stress Responses and Cortisol
1 Sept 2025Open access
Synthesis of New Triazine-Based Ferroptosis Inducers/MMP-Inhibitors for Halting Colon CancerPublisher siteAlexandria Journal of Science and Technology, Synthesis and Characterization of Heterocyclic Compounds
4 Aug 2025
Schistosomiasis: State of the Art and New PerspectivesPublisher siteBENTHAM SCIENCE PUBLISHERS eBooks, Parasites and Host Interactions
4 Aug 2025
Advancements in Antileishmanial Drug Discovery: Targeting Druggable Pathways and Overcoming Treatment ChallengesPublisher siteBENTHAM SCIENCE PUBLISHERS eBooks, Research on Leishmaniasis Studies
10 Jul 2025Open access
From Antiretroviral to Antibacterial: Deep-Learning-Accelerated Repurposing and In Vitro Validation of Efavirenz Against Gram-Positive BacteriaPublisher siteMolecules, HIV/AIDS drug development and treatment
25 Apr 20253cites
Ultrasmall lactoferrin/lipid multicompartmental nanomedicine-based reprogramming of glycolysis in triple-negative breast cancer via HDAC6/LDH axis enhances cancer immunotherapyPublisher siteChemical Engineering Journal, Graphene and Nanomaterials Applications
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Mohamed?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you